Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cuzick

Showing results (211-220 of 229) with videos related to

Pageof 23
Sort By:
Oncogene|October 9, 2007
Complex patterns of ETS gene alteration arise during cancer development in the human prostateJ Clark, G Attard, S Jhavar, et al.
British Journal of Cancer|May 23, 2013
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancerJ Cuzick, Z H Yang, G Fisher, et al.
Lancet (London, England)|December 12, 2003
Management of women who test positive for high-risk types of human papillomavirus: the HART studyJ Cuzick, A Szarewski, H Cubie, et al.
British Journal of Cancer|February 1, 2014
Focal amplification of the androgen receptor gene in hormone-naive human prostate cancerS Merson, Z H Yang, D Brewer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association StudyW Jonat, M Kaufmann, W Sauerbrei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2015
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtypeM Gnant, I Sestak, M Filipits, et al.
Oncogene|July 20, 2007
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerG Attard, J Clark, L Ambroisine, et al.
Journal of Internal Medicine|February 2, 2012
Prevention of breast cancer in the context of a national breast screening programmeA Howell, S Astley, J Warwick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2014
Estimates of benefits and harms of prophylactic use of aspirin in the general populationJ Cuzick, M A Thorat, C Bosetti, et al.
International Journal of Obesity (2005)|October 6, 2010
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight womenM N Harvie, M Pegington, M P Mattson, et al.
Pageof 23

Showing results (211-220 of 229) with videos related to

Sort By:
Pageof 23
Oncogene|October 9, 2007
Complex patterns of ETS gene alteration arise during cancer development in the human prostateJ Clark, G Attard, S Jhavar, et al.
British Journal of Cancer|May 23, 2013
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancerJ Cuzick, Z H Yang, G Fisher, et al.
Lancet (London, England)|December 12, 2003
Management of women who test positive for high-risk types of human papillomavirus: the HART studyJ Cuzick, A Szarewski, H Cubie, et al.
British Journal of Cancer|February 1, 2014
Focal amplification of the androgen receptor gene in hormone-naive human prostate cancerS Merson, Z H Yang, D Brewer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association StudyW Jonat, M Kaufmann, W Sauerbrei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2015
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtypeM Gnant, I Sestak, M Filipits, et al.
Oncogene|July 20, 2007
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerG Attard, J Clark, L Ambroisine, et al.
Journal of Internal Medicine|February 2, 2012
Prevention of breast cancer in the context of a national breast screening programmeA Howell, S Astley, J Warwick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2014
Estimates of benefits and harms of prophylactic use of aspirin in the general populationJ Cuzick, M A Thorat, C Bosetti, et al.
International Journal of Obesity (2005)|October 6, 2010
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight womenM N Harvie, M Pegington, M P Mattson, et al.
Pageof 23